Ausgabe 3/2013
Including PIH Articles on New clinical and basic aspects of graft-versus-host disease
Inhalt (17 Artikel)
Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot–Leyden crystals
Gordon Taylor, Adam Ivey, Benedict Milner, David Grimwade, Dominic Culligan
Waldenström macroglobulinemia with cryoglobulinemia revealed by amorphous deposits on blood smear
Eric Guiheneuf, Emilie Celeste, Jean-François Claisse, Claire Espanel
Meningeal myelomatosis developed after treatment with novel agents
Mikiko Ise, Chikara Sakai, Kyoya Kumagai
Guest Editorial: new basic and clinical aspects of graft-versus-host disease: what can we do without “Doc” Brown’s help?
Akiyoshi Takami
Graft-versus-host disease biomarkers: omics and personalized medicine
Sophie Paczesny, Nisha Raiker, Sam Brooks, Christy Mumaw
Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses
Yoshinobu Maeda
The role of non-HLA gene polymorphisms in graft-versus-host disease
Akiyoshi Takami
Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia
Tatsuhiro Sakamoto, Naoshi Obara, Naoki Kurita, Mamiko Sakata-Yanagimoto, Hidekazu Nishikii, Yasuhisa Yokoyama, Kazumi Suzukawa, Yuichi Hasegawa, Shigeru Chiba
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study
Shinya Katsutani, Yoshiaki Tomiyama, Akiro Kimura, Yoshitaka Miyakawa, Shinichiro Okamoto, Yasushi Okoshi, Haruhiko Ninomiya, Hiroshi Kosugi, Kazuyoshi Ishii, Yasuo Ikeda, Toshihiro Hattori, Koichi Katsura, Yuzuru Kanakura
Expression of myeloid antigens on lymphoblast surface in childhood acute lymphoblastic leukemia at diagnosis and its effect on early response to treatment: a preliminary report
Grazyna Sobol-Milejska, Agnieszka Mizia-Malarz, Halina Wos
Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
Toshihiro Miyamoto, Goichi Yoshimoto, Tomohiko Kamimura, Tsuyoshi Muta, Shuichiro Takashima, Yoshikiyo Ito, Motoaki Shiratsuchi, Ilseung Choi, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Yasushi Takamatsu, Takanori Teshima, Koichi Akashi
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation
Moon Ki Choi, Eun Suk Kang, Dae Won Kim, Yonug Hyeh Ko, Hyeri Seok, Jin Hong Park, Dae Hee Pyo, Do Hoon Lim, Seok Jin Kim, Won Seog Kim
B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID
Satoru Kumaki, Yoji Sasahara, Yoshiro Kamachi, Hideki Muramatsu, Tomohiro Morio, Kumiko Goi, Kanji Sugita, Tomonari Urabe, Hidetoshi Takada, Seiji Kojima, Shigeru Tsuchiya, Toshirou Hara
Nilotinib-induced interstitial lung disease
Se-Il Go, Won Sup Lee, Gyeong-Won Lee, Jung Hun Kang, Myung Hee Kang, Jeong-Hee Lee, Hoon-Gu Kim
Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis
Hisao Nagoshi, Junya Kuroda, Tsutomu Kobayashi, Saori Maegawa, Yoshiaki Chinen, Miki Kiyota, Ryuko Nakayama, Shinsuke Mizutani, Yuji Shimura, Mio Yamamoto-Sugitani, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki
Are regimens containing rituximab effective in the initial treatment of Epstein–Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
Shinsaku Imashuku, Naoko Kudo, Kagekatsu Kubo, Akihiro Yachie